image by: HWN

HWN Suggests

Quest for a Unifying Diagnosis: Felty Syndrome?

There is a lack of significant data evaluating various treatment options for this rare clinical condition. However, the therapeutics used have focused mainly on resolving neutropenia. First-line treatments most often include DMARDS, usually methotrexate, followed by granulocyte colony-stimulating factor (G-CSF) and splenectomy. Compared to uncomplicated RA, the prognosis is much poorer for these patients due to recurrent infections. Infectious endocarditis portends increased morbidity and mortality as one of the most common life-threatening infectious syndromes.

read full article

Featured

 Felty’s syndrome

Felty’s syndrome often comes along with diagnostic challenges, as there are many conditions/diseases with similar manifestations... Methotrexate and rituximab are still the mainstay of treatment and in most cases, Felty’s syndrome is sufficiently controlled by these drugs. But there are difficult-to-treat cases, necessitating new treatment options. Maybe JAK inhibitors might prove useful in the future, as there have been promising results in patients with T-LGL leukemia, which seems to share some pathomechanisms with Felty’s syndrome.

Articles of Interest

Atypical Presentation of Felty Syndrome...

The atypical presentation of Felty syndrome, even without arthritis symptoms, needs further evaluation. Timely diagnosis of neutropenia and splenomegaly in patients with rheumatoid arthritis without joint symptoms is crucial for a better prognosis. Despite the rarity of the condition, clinicians should have a high index of suspicion, and multidisciplinary collaboration between rheumatology, hematology, and other specialists is required for accurate diagnosis.

Felty Syndrome

It is important to remember that the diagnosis of FS may be masked in patients who present with infection, since active bacterial infection raises the WBC count to normal or slightly elevated – the neutropenia reappears shortly after successful treatment (Kay, 2017).

Felty Syndrome Management: Treatment, Strategies & Education

Felty syndrome management is crucial for those dealing with this rare, yet serious condition, considering its clinical presentation and clinical features, and sometimes requiring splenectomy. This autoimmune disorder, characterized by rheumatoid arthritis, an enlarged spleen, leukopenia, and a low white blood cell count due to autoantibodies, can be challenging to handle without proper guidance as it is a rare disease. Historically, treatment options were limited and often ineffective.

Felty syndrome: a case report

Felty syndrome is a rare manifestation of chronic rheumatoid arthritis in which patients develop extraarticular features of hepatosplenomegaly and neutropenia. The typical presentation of Felty syndrome is in Caucasians, females, and patients with long-standing rheumatoid arthritis of 10 or more years.

Felty’s syndrome as the first presentation of rheumatoid arthritis

Felty's syndrome (FS) is a rare, autoimmune disease occurring in < 1% of patients with rheumatoid arthritis (RA) and comprising a triad of persistent idiopathic neutropenia, splenomegaly and RA. In some affected individuals, FS may develop when the symptoms and signs of RA have subsided or are absent. In this case, FS may remain undiagnosed. In rare instances, the development of FS may precede the development of the clinical manifestation of RA.

Felty’s Syndrome Presents Differently in Pediatric Patients

In a very small number of cases, Felty’s syndrome has appeared in young people with chronic juvenile idiopathic arthritis (JIA).

Felty’s Syndrome: Triad Not Always Evident

First line treatment: methotrexate. Second line: rituximab. Third line: glucocorticoids.

Neutropenia and Felty Syndrome in the Twenty-First Century: Redefining Ancient Concepts in Rheumatoid Arthritis Patients

In the 21st century, neutropenia in RA patients is most commonly related to biologics, mostly IL6 inhibitors and methotrexate. Episodes are mild, acute, with low RA activity, and associated with severe infections in few cases. Felty syndrome is rare.

Resources

RheumaKnowledgy

Although patients with Felty’s syndrome have evidence of deforming erosive RA, active synovitis may not be present at the time of diagnosis. Patients often display other extraarticular manifestations (e.g., rheumatoid nodules, Sjögren’s syndrome, rheumatoid vasculitis, episcleritis, pericarditis, or neuropathy) and may have evidence of weight loss, leg ulcers, recurrent infections, and splenomegaly. Splenomegaly may not be detected in all patients with extraarticular manifestations of RA and leukopenia. However, splenomegaly in Felty’s syndrome may be massive.

Physiopedia

Felty Syndrome (FS), a rare complication of rheumatoid arthritis (RA), was first described by Dr. Augustus Felty in 1924. It is characterized by a triad of symptoms: seropositive RA with severe joint involvement, a low white blood cell count (neutropenia), and an enlarged spleen (splenomegaly). However, the triad is not required for diagnosis. Splenomegaly and severe joint involvement are not always present in some people with FS, and some people can even present with no symptoms. Neutropenia is the hallmark symptom of FS and is key for diagnosis.

StatPearls

Felty syndrome is a rare extra-articular manifestation of seropositive rheumatoid arthritis characterized by RA, neutropenia, and splenomegaly. While the etiology remains somewhat obscure, baseline data suggests an association with certain human leukocyte antigen (HLA) subtypes.